Does BPC-157 Help Climber's Elbow?
Does BPC-157 help climber’s elbow? It’s an open debate, not a settled thing. Climbers who use it say the peptide quiets the inner-elbow tendon pain and gets them back on the wall sooner — the idea being that BPC-157 speeds soft-tissue healing. Others aren’t sold: they say the hype rides on animal studies rather than climbers, and that it did nothing for their elbow. This post lays out both cases — plus the wrinkle that “climber’s elbow” is really two different injuries people mix up.
The full rundown — the two injuries, the case for BPC-157, and the case against ↓
What is climber’s elbow?
The two patterns:
- Medial epicondylitis — pain where the wrist and finger flexor tendons attach to the inner elbow. It’s the same injury golfers get. Crimping and pulling load these tendons over and over.
- Brachialis strain — pain deeper and toward the front of the elbow, often from dynamic moves, campus boarding, or a hard catch on a dyno.
Despite the “-itis” in the name, this usually isn’t inflammation:
- In chronic cases the tendon breaks down and rebuilds poorly — a process called tendinosis, not tendinitis.
- A 2009 review described it as a continuum — a tendon slides from a reactive, still-recoverable stage through “dysrepair” toward truly degenerative tissue.[2]
- That’s a big part of why rest alone often doesn’t fix a stubborn elbow: degenerative tendon responds to load, not just time off.
What are BPC-157 and TB-500?
- BPC-157 is a lab-made peptide sold online for tissue repair. The name is short for “Body Protection Compound,” and its recipe comes from a protein found in human stomach fluid.
- TB-500 is usually sold with it — the Wolverine stack. It’s a lab-made fragment of a natural protein called thymosin β4, whose wound-healing and cell-movement activity is documented in the research,[3] and which has been through human trials for dry eye, given as an eye drop.[4]
Why do climbers use it for elbow pain?
The logic is simple: a stubborn elbow tendon is a repair problem, and BPC-157 is described in lab research as acting on the machinery repair depends on. The specific claims:
- Tendon cell growth. A 2011 lab study found BPC-157 helped tendon cells (tenocytes) move, grow, and survive stress in a dish.[7]
- Growth-hormone sensitivity. A 2014 lab study found it increased growth-hormone receptors on those same tendon cells.[8]
- New blood vessels. Part of the reasoning is angiogenesis — growing new blood vessels. On the Huberman Lab podcast, that effect was described as its proposed healing mechanism[14] — appealing because tendon heals slowly partly for lack of blood supply.
- Healing a cut tendon. A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal, and offset the healing delay steroids normally cause.[6]
- The TB-500 angle. Thymosin β4, the protein it’s a fragment of, is described in the research as driving cell movement and wound repair[3] — and users apply that to tendon.
What climbers actually use it for, going by their posts:
- Medial epicondylitis or golfer’s elbow that hasn’t resolved with rest.
- Brachialis pain.
- Most often, an elbow that’s already been sore for months and hasn’t responded to a layoff.
How do people use it?
- On forums like MESO-Rx, users describe injecting BPC-157 — often stacked with TB-500 — for tendon and joint pain, including the elbow.[5]
- The recurring worry is whether the vial they bought actually contains what the label says.
What do users report?
- On MESO-Rx, one user logged a TB-500 cycle and reported little effect until week four, when a golfer’s-elbow injury started resolving faster, alongside more visible veins.[11]
- Reports on BPC-157 specifically are mixed — some describe fast relief; others say it did nothing, and both forums flag how often the product is fake or underdosed.[5][12]
What some users report (anecdotal)
- Faster elbow pain relief
- Less stiffness
- More visible veins
- Quicker return to climbing
What other users report (anecdotal)
- No effect at all
- Wasted money on fakes
- Doubts it did anything
Two things worth keeping in mind:
- These are self-selected reports from anonymous posters, not measured outcomes.
- Elbow injuries change on their own over time, and BPC-157 and TB-500 are almost always used together — so a report rarely separates one from the other.
What side effects are reported?
Neither BPC-157 nor TB-500 has a formal human safety study, so there’s no official side-effect list — just forum reports and expert caution.
Reported by forum users (anecdotal)
- Injection-site pain
- Redness, flushing
- Nausea
- Heart palpitations
- Fatigue, lethargy
- Headaches
- Mood changes
- Metallic taste
- Under-eye puffiness
- Temporary bicep soreness
Off-label upsides some users report (anecdotal)
- Better mood
- Less anxiety
- Hair growth
- Better skin
- More flexibility
A few specifics from the forums:
- Users on Reddit’s r/bpc_157, r/Peptides, and r/TBI describe heart palpitations and jumps in resting heart rate after BPC-157, sometimes with chest pain — one, stacking it with TB-500, posted “BPC 157 giving me palpitations and anxiety?” after weeks of daily use.
- TB-500 users raise a theoretical worry tied to its own mechanism: it promotes angiogenesis (new blood-vessel growth), which is how it’s thought to help tissue heal — but that same mechanism is the basis for a concern that it could feed an undetected tumor. This hasn’t been shown to cause cancer in people; the concern is mechanistic, not a reported outcome.
- Purity varies between sellers — gray-market testing has found some material as low as about 55% pure.
And from people with a public platform:
- Physician Peter Attia puts BPC-157 in his lowest-confidence group, noting its animal results haven’t been repeated in people.[13]
- On the Huberman Lab podcast, the main concerns raised were product sourcing and a theoretical cancer risk, since BPC-157 can promote blood-vessel growth.[14]
- In 2023, the FDA placed BPC-157 in a restricted compounding category, alongside 18 other peptides, citing concerns like immune reactions and impurities.[15]
What’s the standard approach to climber’s elbow?
For context on what a peptide would sit alongside or instead of:
- Tell the two injuries apart. Medial epicondylitis and brachialis strain need different rehab, and treating both as generic “elbow tendinitis” is a common reason recovery stalls.
- Load it, don’t just rest it. Because chronic tendon pain is degenerative, gradual load is what drives repair.[2]
- Slow, heavy loading has a track record. The original research on heavy, eccentric loading returned every subject in a small study to full activity in twelve weeks — for the Achilles, though the same principle is applied to the elbow.[16]
- Load the opposite muscles too. A common climbing-specific add-on is training the antagonists — the wrist and finger extensors on the back of the forearm — often as antagonist supersets, to balance out all the pulling that loads the flexor side.
- Time. Degenerative tendon builds slowly and resolves slowly.
What do the studies say?
No study — human or animal — has tested BPC-157 or TB-500 on climber’s elbow. The research the theory rests on is about a different tendon, in a different species:
- A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal, and offset the healing delay steroids normally cause.[6]
- A 2011 lab study found it helped tendon cells move, grow, and survive stress in a dish.[7]
- A 2014 lab study found it increased growth-hormone receptors on those same tendon cells.[8]
- A 2025 review found 35 animal studies and one human study — a small case series on knee pain, not a controlled trial, and nothing about elbows.[1]
- A separate 2025 review reported human data are “extremely limited,” with most research coming from a single lab.[9]
- TB-500 has no human trial of its own; the human trials of thymosin β4, the protein it’s a fragment of, are for dry eye and use an eye drop.[4]
What about PRP?
Platelet-rich plasma (PRP) — a shot made from a patient’s own blood — comes up often as the comparison, because it’s the injectable that has been through controlled human trials for elbow tendon pain (specifically lateral epicondylitis, or tennis elbow — the outer-elbow version of what most climbers get). A meta-analysis of those trials found PRP was not reliably better than a placebo shot for pain or function.[10]
Bottom line
- Climbers use BPC-157 and TB-500 for a stubborn elbow on the strength of the lab work — tendon-cell growth, new blood vessels, and a rat Achilles that healed faster.
- What users report is mixed, and the two are nearly always taken together.
- No study has tested either one on an elbow, in people or animals — what exists is animal and cell-culture work.
- The alternative climbers usually get steered to is progressive loading.
Frequently asked questions
Why do climbers use BPC-157 for elbow pain?
Has BPC-157 been studied for climber's elbow?
Is climber's elbow the same as golfer's elbow?
What has PRP shown for elbow tendon pain?
What's the standard approach to a climber's elbow that won't heal?
What human data exists on TB-500?
References
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. PMID: 40756949. DOI: 10.1177/15563316251355551.
- Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009. PMID: 18812414. DOI: 10.1136/bjsm.2008.051193.
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PMID: 16099219. DOI: 10.1016/j.molmed.2005.07.004.
- RegeneRx Biopharmaceuticals (RGN-259 program). Thymosin β4 ophthalmic solution (RGN-259) in dry eye: randomized controlled trial. Clin Ophthalmol. 2015. DOI: 10.2147/OPTH.S80954.
- MESO-Rx forum members BPC-157 — community discussion thread MESO-Rx forum. n.d.. Source.
- Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006. PMID: 16583442. DOI: 10.1002/jor.20096.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. PMID: 21148156. DOI: 10.1152/japplphysiol.00945.2010.
- Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014. PMID: 25415472. DOI: 10.3390/molecules191119066.
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025. DOI: 10.1007/s12178-025-09990-7.
- Platelet-rich plasma versus placebo for lateral epicondylitis: a systematic review and meta-analysis. Clin Rheumatol. 2020. DOI: 10.1007/s10067-020-05000-y.
- MESO-Rx forum member TB-500 cycle — user log MESO-Rx forum. n.d.. Source.
- LongeCity forum members BPC-157 — community megathread LongeCity forum. n.d.. Source.
- Attia P AMA #83: Peptides — evaluating the science, safety, and hype The Peter Attia Drive (podcast). n.d.. Source.
- Huberman A Benefits & Risks of Peptide Therapeutics for Physical & Mental Health Huberman Lab (podcast). n.d.. Source.
- U.S. Food and Drug Administration 19 peptides placed in Category 2 of the interim 503A bulks list (safety concerns: immunogenicity, peptide-related impurities) FDA regulatory action, Sept 29, 2023. 2023. Source.
- Alfredson H, Pietilä T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998. PMID: 9617396. DOI: 10.1177/03635465980260030301.